Targeting the TWEAK-exosomal miR-7 axis attenuates pressure overload induced cardiac remodelling and fibrosis
Background: Cardiac fibrosis contributes to the progression of pathological hypertrophy toward heart failure. However, the mechanisms underlying TWEAK-mediated cardiomyocyte-fibroblast crosstalk remain poorly understood. This study investigated the role of exosomal miR-7 in TWEAK-induced cardiac fibrotic remodeling. Methods: Cardiomyocytes were stimulated with recombinant TWEAK (200 ng/ml), and secreted exosomes were isolated and characterized. Exosomal uptake and profibrotic responses were evaluated in cardiac fibroblasts. The contribution of exosomal miR-7 was investigated using antagomiR-7 and GW4869-mediated inhibition of exosome secretion. Raf-1/AKT and TGF-β1/SMAD signaling were examined. Integrated transcriptomic and metabolomic profiling was performed using RNA sequencing and GC-MS. In vivo validation involved systemic administration of TWEAK-induced exosomes and pharmacological TWEAK inhibition using aurintricarboxylic acid (ATA) in a transverse aortic constriction (TAC) model. Results: Exosomes from TWEAK-stimulated cardiomyocytes were taken up by cardiac fibroblasts, enhancing migration and upregulating α-SMA and TGF-β1. TWEAK enriched miR-7 in these exosomes, raising miR-7 levels in recipient fibroblasts. Inhibiting miR-7 attenuated fibroblast activation, while blocking exosome secretion reduced miR-7 transfer and fibrotic responses. Mechanistically, miR-7 suppressed Raf-1/AKT signaling and enhanced TGF-β1/SMAD signaling. Multi-omics analyses revealed coordinated metabolic and transcriptomic remodeling, including altered energy metabolism, extracellular matrix pathways, and SMAD, PI3K, and hypoxia-related signaling. Systemic administration of miR-7-enriched exosomes exacerbated cardiac fibrosis in vivo, whereas ATA-mediated TWEAK inhibition in TAC reduced hypertrophy, fibrosis, and exosomal miR-7 levels. Conclusion: These findings establish a TWEAK-exosome-miR-7 axis as a mediator of cardiomyocyte-fibroblast crosstalk, identifying exosomal miR-7 as a key regulator of cardiac fibrotic remodeling and TWEAK as a potential therapeutic target.
Authors
- Kashif Hanif (ORCID: https://orcid.org/0000-0001-6088-6024)
- Shishir Kumar Gupta (ORCID: https://orcid.org/0000-0003-2554-4031)
- Prabha Burman
- Pragya Bharati
- Manendra Singh Tomar (ORCID: https://orcid.org/0000-0003-4725-8263)
- Kumaravelu Jagavelu (ORCID: https://orcid.org/0000-0002-9235-0600)
- Baisakhi Moharana (ORCID: https://orcid.org/0000-0002-0098-6135)
- Ashutosh Shrivastava (ORCID: https://orcid.org/0000-0001-5113-3258)
- Azma Khatoon
- Saumya Tripathi
Institutions
- Central Drug Research Institute (IN)
- King George's Medical University (IN)
- Centre of Biomedical Research (IN)
- Academy of Scientific and Innovative Research (IN)
Publication Details
- Journal
- Authorea
- Published
- 2026-11-20
- DOI
- https://doi.org/10.22541/authorea.15012557/v1
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- preprint
Funders
- Council of Scientific and Industrial Research, India